The "Hub" Of Biotherapuetic Intelligence
Dr. Jennifer Bath, CEO & President of ImmunoPrecise Antibodies Ltd. IPA was recently interviewed by Benzinga. ImmunoPrecise is a biotherapeutic research…
Stay updated with breaking news from Jennifer Bath. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dr. Jennifer Bath, CEO & President of ImmunoPrecise Antibodies Ltd. IPA was recently interviewed by Benzinga. ImmunoPrecise is a biotherapeutic research…
IPA , an artificial intelligence-driven biotherapeutic research and technology company, today reported financial results for its second quarter of the 2024 fiscal year , which ended October 31,...
ImmunoPrecise Antibodies Welcomes Mitch Levine To Its Board Of Directors, ...
ImmunoPrecise Antibodies (NASDAQ: IPA) (“IPA”), a leading company in AI-driven biotherapeutic research and technology, has recently announced important changes to its Board of Directors and upcoming financial reporting activities.
ImmunoPrecise Antibodies Ltd. , a leader in AI-driven biotherapeutic research and technology, is pleased to announce important Board of Director changes and upcoming financial reporting...